Back to search

Article

Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy

2026-02-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Resistance to immune checkpoint inhibitors represents a major therapeutic challenge, as less than 50% of patients with melanoma achieve long-term response to immune checkpoint inhibitor therapy. One mechanism of acquired resistance involves somatic mutations, such as loss of beta-2 microglobulin ( B2m ), that enable tumor cells to evade T cell-mediated killing. <h4>Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99dbd377-3334-5ea4-821d-a78f9728a0f2
DOI
10.64898/2026.02.05.704029
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyDOI 10.64898/2026.02.05.704029
Select a neighboring publication to make it the new centre.